Navigation Links
Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects
Date:3/4/2013

NEW YORK, March 4, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects

http://www.reportlinker.com/p01109062/Prefilled-Syringes-to-2018---Devices-Drugs-Markets-Players-and-Prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Highlights • Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics

• Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

• Examines design factors, material selection issues, technologies and market development issues

• Charts product data, market share, and forecasts to 2018

• Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Table of Contents Executive Summary

Injectable Drug Market Dynamics

Competitive Landscape

The Device Manufacturing Universe

Supply Chain Dynamics

Supply Chain Structure

Supplier Relationships and Supply Risk

Supplier Integration

Captive Capacity vs CMOs

Demand Drivers

Drug Discovery and Development Trends

Patient and Caregiver Sentiment

Diseases and Indications

Patient Demographics

The Prefilled Syringe Ecosystem and Supply Chain

Materials and Components

Evolving Technology

Alliances & Relationships

Syringe Manufacturers

Technology/Capabilities

Geographic Reach

Barriers to Entry

CMO's – Beyond Fill & Finish

Value-added Services

Market Proximity

CMO Evolution

Testing, Services and Validation

Prefilled Syringes – Design Factors

Drug Stability and Shelf Life

Material Selection Issues

Point-of-Use Reconstitution

Caregiver Safety

Needle Configuration Strategies

Human Engineering/Ergonomics

Prefilled Syringes – Commercial Devices

Prefillable Therapeutic Injectables

Glass Prefillable Syringes

Plastic Prefillable Syringes

Ready-to-Fill Safety Syringes

Specialty Prefillable SyringesFlush SyringesDiluent SyringesImaging Agent Syringes

Competing Prefilled Devices

Bundled PFS + Autoinjector

Prefilled Pen Injectors

Prefilled Needle-free Injectors

Prefilled Syringe Market Segments

Prefilled Therapeutic Injectables

AnaphylaxisAnticoagulantsAutoimmune DiseasesEmergency MedicineHepatitisHematopoietics and Related Erythropoiesis Stimulating ProteinsMetabolic Diseases NeurologyReproductive HealthVaccines?Non-API Prefilled Syringe Segments

Catheterization

Reconstitution

Diagnostic Imaging?

Market Factors

Self-Administration and Patient Compliance

Insurance, Reimbursement, and Managed Care

Regulatory Guidance and Product Approvals

The Evolving PFS Ecosystem

Prefilled Syringes – Market Participant Profiles

To order this report:Drug_Delivery_Technology Industry: Prefilled Syringes to 2018 - Devices, Drugs, Markets, Players and Prospects

Contact Clare: clare@reportlinker.com

US:(339) 368 6001

Intl:+1 339 368 6001


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
2. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
3. West Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes
4. Microneedle Drug Patches, Syringes & Systems
5. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
6. Adoption of Prefillable Syringes Rising, Especially In High-cost Drug Applications to Contain Wastage, Notes Frost & Sullivan
7. BD Announces Agreement to Acquire Safety Syringes, Inc.
8. Autoinjectors to 2018 - Devices, Therapeutics, Markets, Strategies and Prospects
9. Brazil Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
10. United Kingdom Ophthalmic Devices Market Outlook to 2018 - Vision Care, Intraocular Lens (IOL), Cataract Surgery Devices, Ophthalmic Diagnostic Equipment, Refractive Surgery Devices, Vitreo Retinal Surgery Devices and Others
11. India Wound Care Management Market Outlook to 2018 - Advanced Wound Management, Wound Closure Devices, Pressure Relief Devices, Ostomy Drainage Bags and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to its expanding ... of Medicine and NEJM Journal Watch, announces the release of NEJM Knowledge+ ... a panel of pediatricians from leading medical centers. The content was then reviewed ...
(Date:3/27/2017)... Little Rock, AR (PRWEB) , ... March 27, 2017 , ... ... the CMSA National Board of Directors on June 30, 2017. CMSA’s membership has ... board. In addition to our current Military Advisory position, a new VA Advisory position ...
(Date:3/27/2017)... ... 27, 2017 , ... Osteitis pubis may be commonplace and ... it occurs when the muscles around the pelvis become inflamed. Over time, untreated ... torso, as well as accompanying tenderness and weakness. Without proper intervention, it can ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, ... second year in a row; they are the recipient of the prestigious “Best ... voted on the award at Design Connections 2017. Top A&D professionals from leading ...
Breaking Medicine News(10 mins):